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ABSTRACT 
Objective: The study aims for the design and evaluation of floating tablets of emtricitabine (EMT), post oral administration to sustain the release 
and enhance gastric residence time (GRT).  
Methods: EMT is a nucleoside reverse-transcriptase inhibitor for the prevention and treatment of human immunodeficiency virus (HIV) infection. 
The investigation was considered to formulate a floating tablet of EMT with various agents. The formulation included with various concentrations of 
hydroxypropyl methylcellulose (HPMC) k4m, ethylcellulose, microcrystalline cellulose, polyvinylpyrrolidone (PVP) by wet granulation method. 
Various parameters for the prepared formulations were evaluated for weight variation, thickness, hardness, friability, floating lag time (FLT), total 
floating time (TFT), swelling index, in vitro drug release, and fourier-transform infrared spectroscopy (FTIR) studies.  
Results: The best formulation F1 exhibited 88.28% release in 24 h duration, with a floating lag time of 7 min and swelling index of 52.1% and drug 
content was determined to be 98.27%. The release mechanism was determined to be first order with higuchi release kinetics displaying diffusion 
along with the dissolution of the EMT from the tablet by non fickian mechanism.  
Conclusion: EMT tablets showed an increased GRT with a sustained release for 24 h thereby allowing a better window for absorption consequently 
improve the therapeutic effect of the drug.  
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Sustained drug delivery system yields a perpetual oral delivery of 
drugs at conceivable and reproducible kinetics for a preordained 
period throughout the course of gastrointestinal (GI) transit [1]. 
Conventional oral dosage forms agonize from mainly two 
predicaments the short GRT and unpredictable gastric emptying 
time. A relatively short GI transit time of most drug products hinder 
the formulation of single daily dosage forms. Altering the gastric 
emptying can overwhelm these problems. Therefore, it is desirable, 
to formulate a sustained release dosage form that gives an extended 
GI residence time. One of the most workable approaches for 
achieving a sustained and predictable drug delivery profiles in the GI 
tract is to control the GRT using gastro retentive dosage forms that 
offer a novel and better option for drug delivery [2]. 
Dosage forms that can be perpetuated in the stomach are called 
gastro retentive drug delivery systems. Gastro retentive systems can 
remain in the gastric region for several hours and hence significantly 
sustain the GRT of drugs. Sustained gastric retention improves 
bioavailability, reduces drug waste, and improves solubility for 
drugs that are less soluble in a high pH environment. Gastro 
retentive floating tablets have emerged as an efficient means of 
ameliorating the bioavailability of many drugs [3, 4]. Rapid GI transit 
could result in incomplete drug release from the drug delivery 
system above the absorption zone leading to diminished efficacy of 
administered dose.  
Hence, it was chosen in the present examination as a satisfactory 
applicant for the design of gastric floating drug delivery system for 
better retention time and bioavailability [5-7]. 
The present study was to develop a floatable drug delivery system of 
EMT using HPMC k4m, ethylcellulose, microcrystalline cellulose, 
sodium hydrogen carbonate, isopropyl alcohol for sustained drug 
delivery and gastric retentive property. Thus, the study aims to 
improve the oral bioavailability of the drug and to achieve extended 
retention in the stomach which may result in sustained absorption. 
MATERIALS AND METHODS 
Materials 
EMT and HPMC k4m were procured from yarrow chem products 
(Mumbai, India), ethylcellulose and magnesium stearate were 
procured from loba chemie pvt. ltd. (Mumbai, India), 
microcrystalline cellulose, PVP and talc, were purchased from 
molychem (Mumbai, India), sodium hydrogen carbonate was 
procured from finar chemicals pvt. Ltd (Ahmedabad, India), and 
isopropyl alcohol was purchased from SRL pvt. Ltd (Mumbai, India). 
Methods 
Preparation of floating tablets of emtricitabine  
EMT floating tablets were prepared by wet granulation method 
employing sodium hydrogen carbonate as gas-generating agent [8]. 
Microcrystalline cellulose and ethyl cellulose were used as release 
rate-controlling agents. The concentrations of the excipients were 
optimized as showed in (table 1). The drug was mixed with the 
release rate retarding polymers and other excipients. HPMC k4m 
was added in ascending order of its weight. The weighed powders 
were triturated well in a mortar pestle. 10 mg of PVP was dissolved 
in a sufficient quantity of isopropyl alcohol. This mixture was added 
drop by drop to the powder to obtain wet blend sufficient to form 
granules. This mass was allowed to pass through a sieve. The 
obtained granules were kept in an oven at 50℃ for eliminating 
moisture from the granules. Finally, magnesium stearate and talc 
were added. About 300 mg of granules were weighed accurately and 
fed into the die and compressed using 12 mm round surface 
punches. 
Evaluation of EMT floating tablets  
EMT floating tablets were scrutinized for post-compression 
parameters like weight variation, thickness, hardness, friability, 
floating lag time, total floating time, swelling index, in vitro drug 
release, and drug excipient compatibility study–FTIR [9]. 
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Table 1: Composition of gastroretentive tablet formulation of emtricitabine 
Ingredients (mg) F1 F2 F3 F4 F5 F6 
EMT 50 50 50 50 50 50 
HPMC k4m 144 154 162 184 195 206 
Ethyl cellulose 18 12 8 32 21 10 
Microcrystalline cellulose 54 50 46 - - - 
Sodium hydrogen carbonate 20 20 20 20 20 20 
PVP 10 10 10 10 10 10 
Isopropyl Alcohol 0.3 0.3 0.3 0.3 0.3 0.3 
Talc 2 2 2 2 2 2 
Magnesium state 2 2 2 2 2 2 
  
Weight variation 
Weight uniformity was established for the formulated tablets. 
Randomly 20 tablets were selected. They were weighed 
collectively and individually. Average weight was calculated from 
the collective weight. The weight of each tablet was compared with 
the average weight to ascertain whether it is within permissible 
limits or not [10]. 
Hardness  
Hardness of a tablet indicates its ability to withstand mechanical 
shocks while handling. The crushing strength of a tablet was 
determined using Monsanto type hardness tester and expressed in 
kg/cm² [11, 12]. 
Friability 
The friability of a tablet was determined using Roche friabilator. 
Randomly 20 tablets were taken and their weights were weighed. 
They were then transferred into friabilator which was operated at 
25rpm/min for 4 min (100 revolutions). The tablets were weighed 
again for their final weights [13]. And the % friability was then 
calculated by  




Determination of swelling index  
The swelling index measured by studying weight gain. A tablet from 
each formulation was randomly selected and its weight was 
recorded. The weighed tablet from each formulation was transferred 
into a basket of dissolution apparatus using dissolution medium pH 
1.2 buffers at 37±0.5℃. pre-determined intervals up to 12h, the 
tablet from the apparatus was withdrawn and blotted with a tissue 
paper to remove the excess water and recorded its weight on an 
analytical balance [14, 15]. 
Drug content determination  
Powder equivalent to an average weight was dissolved in 10 ml of 
methanol, followed by sonication for 10 min. Then, 1 ml was 
withdrawn and was diluted to 10 ml with 0.1N HCl and was 
measured spectrophotometrically at 291 nm [16]. 
In vitro buoyancy studies  
In vitro buoyancy studies were performed for all the formulations. 
Randomly selected tablets from each formulation were kept in a 100 
ml beaker containing buffer of pH 1.2 as per USP. The time taken for 
the tablet to rise to the surface and float was taken as FLT. The 
duration of time the dosage form constantly remained on the surface 
of the medium was determined as the TFT [17]. 
In vitro dissolution studies  
In vitro drug release of the formulations was carried out using 
USP–type II dissolution apparatus at 37±0.5℃ using 900 ml of 
0.1N HCl (pH 1.2) as the dissolution medium at 50 rpm. One EMT 
tablet from each formulation was placed in each basket and was 
allowed to run for 24 h. Aliquot of 5 ml was withdrawn at 
predetermined interval subsequently replaced with an equivalent 
amount of fresh buffer to sustain a constant volume. Collected 
samples were suitably diluted as required and analysed at 291 nm 
spectrophotometrically [18]. 
Drug excipient compatibility studies  
It is vital that formulations stress on physiochemical and biological 
characteristics of active and excipient employed for product 
development. Hence it suggests that compatibility of active and 
excipients to is essential for a stable and safe product. FTIR is an 
effective analytical technique utilized to study chemical interactions 
within active and excipients in the formulations. Active and excipient 
were mixed extensively with potassium bromide. The samples were 
introduced into diffuse reflectance sampler, and subsequent 
spectrums were recorded in wavelength region 4000-400 cm-1
RESULTS AND DISCUSSION 
 in 
FTIR [19]. 
Drug release kinetics  
In order to comprehend the underlying mechanisms involved in the 
release pattern, the dissolution data were fitted into zero-order, first 
order, and Higuchi’s and Korsmeyer models. These kinetic equations 
were applied to interpret the release rate of the drug from the 
matrix system [20-22]. 
EMT floating tablets were formulated to increase the GRT; thereby 
drug can sustain in the stomach for a longer period and benefit in 
sustained release for a minimum of 24 h. The tablets were 
formulated employing various polymers like HPMC k4m, 
ethylcellulose, microcrystalline cellulose, sodium hydrogen 
carbonate, PVP, isopropyl alcohol by wet granulation. When an 
amalgamation of gas entrapping along with release controlling 
system, the use of disintegrating agent is very significant which does 
not quickly break the matrix and also permit slow disintegration of 
the swollen matrix. Talc and magnesium stearate were used for their 
glidant and lubricant property. The prepared formulations were 
evaluated for weight variation, thickness, hardness, friability, 
floating lag time, total floating time, swelling index, in vitro drug 
release, and drug excipient compatibility study–FTIR and release 
kinetics. 
Post–compression evaluation tests for formulated tablets  
Post-compression parameters such as weight variation, thickness, 
hardness and friability were assessed for formulated tablets. All 
prepared formulations retained their off-white appearance with no 
visible crevices, in a flat-faced circular shape. The results for weight 
variation, thickness exhibited were within the limits. Minor variation 
in the tablet hardness was observed mostly due to trivial variation in 
compressional force. The polymers blend of HPMC k4m, 
ethylcellulose, microcrystalline cellulose yielded harder tablets 
when compared with tablets containing only a blend of HPMC k4m, 
ethyl cellulose. Friability results were determined to be within 
limits, it was observed that as the concentration of the HPMC k4m 
the friability of the tablets decreased. The results are given in (table 
2), the results revealed the tablets are mechanically strong. 
Weight variation  
The EMT tablets were evaluated for weight variation and were in the 
range of 300.72±2.75 to 302.10±3.43. The results agreed with 
official limits, no significant deviation from average tablet weight 
courier suggesting consistency of dosage units. 
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Table 2: Results for post–compressional evaluation of EMT tablets 
Formulation code Weight variation* Thickness (mg) # Hardness(mm) * (kg/cm2 Friability) # (%) 
F1 301.37±3.56 4.14±0.03 5.82±0.01 0.22±0.05 
F2 300.35±2.26 4.13±0.05 5.78±0.03 0.23±0.11 
F3 301.00±1.55 4.13±0.02 5.87±0.07 0.11±0.08 
F4 302.10±3.43 4.12±0.04 5.55±0.10 0.23±0.03 
F5 301.03±3.69 4.18±0.04 5.64±0.09 0.11±0.05 




Vernier callipers was used to measure the tablet thickness. The 
thickness of the tablets ranged between 4.12±0.04 to 4.18±0.04 mm. 
Hardness 
Hardness was measured by Monsanto tester. The variances in tablet 
density and porosity resonances with tablet hardness, which 
subsequently govern different release patterns of the drug by 
influencing the rate of penetration of the dissolution media at tablet 
surface. Hardness of the tablets was determined to be in the range of 
5.55±0.10 to 5.87±0.07 kg/cm
mean±SD (n=10) 
2
A consistent drug content in the batch is very essential for delivering 
the accurate dose from the dosage form, the drug content for the 
prepared tablets was in the range of 97.12±0.32% to 98.27±0.22% 
suggesting uniform drug content in prepared formulations. The 
results are given in (table 3). 
In vitro buoyancy studies  
FLT is the time taken by the tablet to rise to the surface after 
introducing in the medium, and float. The gas generated by the 
gas generating agents remain entrapped in the swollen polymer, 
formed post hydration, thereby lowering the tablet density. Once 
the density achieved remain less than the medium, the tablet 
remains buoyant. Results revealing that the formulations with 
blend of polymers of HPMC k4m, ethylcellulose, microcrystalline 
cellulose exhibited less FLT and high TFT (24h) in comparison 
with other formulations where microcrystalline cellulose was 
absent and higher ratios of polymers. The formulation with best 
combination of polymers F1 gave best FLT and TFT.  
From the results it was observed that as the concentrations of 
HPMC k4m the FLT increased and TFT decreased; thus, an 
optimum blend of hydrophilic polymers lead to an efficient 
floating system. The results are given in (table 3). 
In vitro dissolution studies 
. The tablets were recommended 
good tensile strength. 
Friability 
Friability of the prepared tablets was measured by Roche Friabilator 
and determined to be in the range of 0.11±0.06 to 0.23±0.11, the 
friability of all prepared tablets was to be less than 1% which 
suggests acceptable mechanical resistance of the tablets.  
Swelling index  
The extent of swelling was determined by measuring the thickness 
of the tablet prior and after the tablet placed in pH 1.2 buffer. 
Formulation F1 exhibited the highest index of 52.1%, whereas F6 
with minimum of 31.7%. The results are given in (table 3). 
Drug content 
The in vitro dissolution study was carried out for all prepared 
formulations for 24 h shown in (fig. 1). All formulations were 
exhibited good buoyancy. The formulation F1 with a low 
concentration of HPMC k4m showed the maximum release of drug 
when compared to other formulations. High concentration of 
polymer influences the formation of swollen mass that restricted the 
rate of diffusion into the matrix, which may result in retardation the 
drug release. Formulation F3 showed the least release of drug in 24h 
all the formulations released above 60% of the drug in 24h. 
  
 
Fig. 1: In vitro dissolution profiles for EMT floating tablets data expressed in mean±SD (n=3) 
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Table 3: Results for evaluation tests–drug content, swelling index, FLT and TFT of EMT tablets 
Formulation code Drug content* Swelling index (%)  (%) FLT (min) TFT (h) 
F1 98.27±0.22 52.1 7 min  24 
F2 98.16±0.12 49.8 7 min 8 sec 24 
F3 99.40±0.39 48.0 11 min  23 
F4 97.58±0.28 45.3 13 min 12 sec 21 
F5 98.62±0.41 31.7 14 min 3 sec 20 
F6 97.12±0.32 32.6 15 min  20 
*
 
Drug excipient compatibility studies 
mean±SD (n=6) 
For understanding the compatibility between the pure EMT and 
the formulation components, FTIR was recorded for both pure 
EMT and the formulation components along with EMT 
individually, characteristic functional group peaks appeared in 
both samples at 3400 cm-1 signifying the N-H stretching, C=O 
stretching at 1600 cm-1, −OH bending at 1420 cm-1 and C−N 
stretching at 1250 cm-1
  
 all the results of FTIR indicating the there 
was no predominant interactions between the drug and the 
formulation components. FTIR peaks for both pure EMT and the 
formulation showed in (fig. 2a and 2b). 
 
Fig. 2a: FTIR of EMT pure drug 
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Drug release kinetics 
From the obtained data of in vitro dissolution studies of EMT tablets, 
the best and optimized formulation F1 were fitted into various 
models, zero order, first order, and Higuchi’s and Korsmeyer models. 
Release kinetics are discussed in (table 4). From the models, it was 
determined that all formulations followed diffusion, dissolution 
mechanism throughout the release. The best formulation F1 
formulations observed diffusion besides dissolution by non fickian 
mechanism. The release mechanism was determined to be first 
order with higuchi release kinetics showing diffusion besides 
dissolution by non fickian mechanism. 
 
Table 4: Release kinetics of F1 formulation 
Formulation code Zero-order First-order Higuchi model Peppas model 
F1 0.92 0.99 0.995 0.64 
 
CONCLUSION 
The study was undertaken to develop and formulate a gastro-
retentive drug delivery system of EMT to enhance the therapeutic 
effect and by achieving a sustained drug release over a period of 24h. 
The EMT is used along with other medications to treat human 
immunodeficiency virus (HIV) infection. EMT floating tablets were 
prepared using HPMCk4m, ethylcellulose, microcrystalline cellulose 
in various ratios by wet granulation method, employing sodium 
hydrogen carbonate as gas generating agent. From the obtained 
results, it could be concluded that formulation F1 offered best 
sustain release along with FLT of 7 min and TFT of 24 h and in vitro 
drug release of 88.28% by the end of 24h. 
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